Författare: Nilsson Sven E, Nilsson Martin S, Nilsson Erik D, Nilsson Peter M
Titel: Långtidsöverlevnaden vid diabetes har successivt förbättrats. Lång sjukdomsduration kan ge information om protektiva möjligheter [summary] 2005 nr 28 sid 2066-70
Ämnesord:
Diabeteskomplikationer
Typ 1-diabetes
Överlevnadsfrekvens
Sök liknande artiklar
Summary:
Studies on patients with long-term diabetes survival without severe complications can give information about protective factors. Therefore, the present study aims to describe the long-term survival of patients with diabetes during successive periods following the introduction of insulin therapy in 1923. After registration in 1973 of the first local diabetic patient in Jönköping with a fifty-year survival, this group has successively increased. Of those who were diagnosed during the period 1940 through 1949 there was a fifty-year survival in about one third. The successively better survival emphasises the importance of therapeutic progress. The study found no difference in diabetes control between those surviving 50 years and those with an age-matched group with a survival of 15 years. The insulin dose tended to decrease after 30 years duration. Peripheral vibration sensibility as well as renal function deteriorated by longer duration. The serum ratio of HDL-cholesterol to triglycerides increased. The frequency of glaucoma, cataract, and a history of myocardial infarction increased. In spite of long duration, one third of the sample had escaped serious retinopathy.
Sven E Nilsson, Martin S Nilsson, Erik D Nilsson, Peter M Nilsson
Correspondence: Sven E Nilsson, Institutet för gerontologi, SE-551 11 Jönköping, Sweden sven.nilsson@hhj.hj.se
Referenser:
1. Petrén K. Behandlung des Diabetes mellitus. In: Handbuch der gesamten Therapie in sieben Bänden. Bd 1. Jena. (Ed. Gustav Fischer). 1926:827-75.
2. Marks HH. Longevity and mortality of diabetics. Am J Publ Health Ass 1965;55:416-23.
3. Blöch J, Korp W. Diabetiker aus der Vorinsulinära. Ein bericht über 10 Zuckerkranke mit 40-jähriger Diabetesdauer. Wien Klin Wochenschr 1963;75:378-80.
4. Bain SC, Gill GV, Dyer PH, Jones AF, Murphy M, Jones KE, et al. Characteristics of type 1 diabetes of over 50 years duration (The Golden Years Cohort). Diabetic Med 2003;20:808-11.
5. Nilsson SE, Kuylenstierna J, Andersson PO, Sjöstrand Å, Tisell A. Resultat av Jönköpingsundersökning: omfattande hypertonimedicinering hos diabetiker. Läkartidningen 1982;82:1048-51.
6. Uvstedt HJ, Olsen E. Incidence of diabetes mellitus in Oslo, Norway, 1956-65. Br J Prev Soc Med 1977;13:251-57.
7. Cristau B, Kronmann H, Christy M, Ortved Andersen O, Nerup J. Incidence of insulin-dependent diabetes mellitus (0-29 years at onset) in Denmark. Acta Med Scand 1979 (suppl 624):54-60.
8. Blohmé G, Nyström L, Arnqvist HJ, Lithner F, Littorin B, Olsson PO, et al. Male predominance of Type 1 (insulin-dependent) diabetes mellitus in young adults: results from a 5-year prospective nationwide study of the 15-34 year age group in Sweden. Diabetologia 1992;35:56-62.
9. Gold CH. Malmberg B. McClearn GE. Pedersen NL. Berg S. Gender and health: A study of older unlike-sex twins. J Geront Soc Sci 2002;57B:S168-76.
10. Nilsson SE, Evrin PE, Tryding N, Berg S, McClearn G, Johansson B. Biochemical values in persons older than 82 years of age: report from a population-based study of twins; Scand J Clin Lab Invest 2003;63:1-14.
11. Statistisk Årsbok 2004; Norstedts Tryckeri AB. Stockholm.
12. Heller DA, de Faire U, Pedersen NL, Dahlén G, McClearn GE. Genetic and environmental influences on serum lipid levels in twins. N Engl J Med 1993; 328:1159-56.
13. Middelberg RP, Spector TD, Swaminathan R, Snieder H. Genetic and environmental influences on lipids, lipoproteins, and apolipoproteins: effects of menopause. Arterioscler Thromb Vasc Biol 2002;22:1142-47.
14. Poulsen JE. Diabetes mellitus. Ugeskr læger 1964;126:153-65.
15. Shepherd GR. Diabetes of juvenile onset with 40 years’ survival and no gross damage. Arch Intern Med 1971;128:284-90.
16. Korp W, Zweymüller E. 50 Jahre Insulinbehandlung an der Wiener Kinderklinik - das Schicksal zuckerkranken Kinder aus der ersten Insulinära. Wien Klin Wochenschr 1973;85:385-90.
17. Agardh D, Gaur LK, Agardh E, Landin-Olsson M, Agardh CD, Lernmark A. HLA-DQB1*0201/0302 is associated with severe retinopathy in patients with IDDM. Diabetologia 1996;39:1313-17.
18. Ko BC, Lam KS, Wat NM, Chung SS. An (AC)n dinucleotide repeat polymorphic marker at the 5`-end of the aldose reductase gene is associated with early-onset diabetic retinopathy in NIDDM patients. Diabetes 1995;44:727-732.
19. Borch-Johnsen K, Nissen H, Salling N, Henricksen E, Kreiner S, Deckert T. et al. The natural history of insulin-dependent diabetes in Denmark; Long-term survival - who and why. Diabetic Med 1987;4:211-16.
20. Klein BE, Klein R, McBride PE, Cruickshanks KJ, Palta M, Knudtson MD, Moss SE, Reinke JO. Cardiovascular disease, mortality, and retinal microvascular characteristics in type 1 diabetes: Wisconsin epidemiologic study of diabetic retinopathy. Arch Intern Med 2004;164:1917-24.
21. Allen KV, Walker JD. Microalbuminuria and mortality in long-duration type 1 diabetes. Diabetes Care 2003;26:2389-91.
22. Hänninen J, Takala J, Keinanen-Kiukaanniemi S. Albuminuria and other risk factors for mortality in patients with non-insulin-dependent diabetes mellitus aged under 65 years: a population-based prospective 5-year study. Diabetes Res Clin Pract 1999;43:121-26.
23. Östgren CJ, Lindblad U, Melander A, Råstam L. Survival in patients with type 2 diabetes in a Swedish community: Skaraborg hypertension and diabetes project. Diabetes Care 2002;25:1297-1302.
24. Nilsson SE, Nilsson JE, Frostberg N, Emilsson T. The Kristianstad Survey II. Studies in a representative adult diabetic population with special reference to comparison with an adequate control group. Acta Med Scand 1967;Suppl 469:22-23.
